Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 1,946,100 shares, a growth of 25.5% from the January 15th total of 1,551,100 shares. Based on an average daily volume of 200 shares, the short-interest ratio is presently 9,730.5 days.

Ascentage Pharma Group International Stock Performance

OTCMKTS:ASPHF opened at $5.83 on Friday. Ascentage Pharma Group International has a twelve month low of $5.42 and a twelve month high of $6.45. The company has a 50-day moving average of $6.20 and a 200-day moving average of $4.85.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.